Bone Therapeutics: Helping Bone Regenerate, And To Knit Together

 
• By John Davis

Executive Interview: A raft of clinical trial results are expected in the second half of 2018 for Bone Therapeutics' regenerative cell therapy approach to hip osteonecrosis and delayed-union fractures.  

Bone Therapeutics chairman Jean Stephenne (on the left) and CEO Thomas Lienard
Bone Therapeutics's chairman Jean Stephenne (L) and CEO Thomas Lienard • Source: Bone Therapeutics

More from Clinical Trials

More from R&D